Sunshine Biopharma (SBFM) Acquisitions (2018)
Sunshine Biopharma's (SBFM) quarterly Acquisitions came in at $9884.0 in Q4 2018, up 111.6% on a QoQ basis from -$85231.0 in Q3 2018.
Sunshine Biopharma (SBFM) Acquisitions (2018) Analysis & Trends
Sunshine Biopharma (SBFM) has 1 years of Acquisitions data on file, last reported at $9884.0 in Q4 2018.
- Quarterly Acquisitions changed N/A year-over-year to $9884.0 in Q4 2018, while the trailing twelve-month figure through Sep 2019 was $9884.0 (up 300.0% YoY) and the FY2022 annual result came in at $14.3 million, changed N/A from the prior year.
- Acquisitions advanced to $9884.0 in Q4 2018, from -$85231.0 in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $75347.0 in Q2 2018 to a low of -$85231.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Sunshine Biopharma | 1.52 Mn | -12.23 Mn | 2.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 9,884.00 |
| Sep 30, 2018 | -85,231.00 |
| Jun 30, 2018 | 75,347.00 |
| Mar 31, 2018 | 4,942.00 |